MaMome
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
MaMome (Brooklyn InnoSeq Inc., dba MaMome) is a Brooklyn health-technology company co-founded by LIU student Nini Fan, focused on maternal-child health. Its app offers maternal microbiome testing through patented technology, and the company collaborates with OB/GYN clinics. It won the European Innovation Academy's top startup prize and admission to ELabNYC, and in August 2024 received a $295,000 NIH SBIR Phase I grant to develop a microbiome-based diagnostic for gestational diabetes.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- NIH SBIR grant
MaMome received a $295,000 NIH SBIR Phase I grant to develop a microbiome-based diagnostic for gestational diabetes mellitus, in collaboration with researchers at the UConn School of Medicine.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.